UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The pathogenesis, diagnosis and treatment of Raynaud phenomenon

Nature reviews. Rheumatology, 2012-08, Vol.8 (8), p.469-479

Herrick, Ariane L

2012

Volltextzugriff (PDF)

Pathogenesis of Raynaud's phenomenon

Rheumatology (Oxford, England), 2005-05, Vol.44 (5), p.587-596

HERRICK, A. L

2005

Volltextzugriff (PDF)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

Nature reviews. Rheumatology, 2022-05, Vol.18 (5), p.276-285

2022

Volltextzugriff (PDF)

Recent advances in the pathogenesis and management of Raynaudʼs phenomenon and digital ulcers

Current opinion in rheumatology, 2016-11, Vol.28 (6), p.577-585

Herrick, Ariane L

2016

Volltextzugriff (PDF)

Onset of breast development in a longitudinal cohort

Pediatrics (Evanston), 2013-12, Vol.132 (6), p.1019-1027

2013

Volltextzugriff (PDF)

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

Annals of the Rheumatic Diseases, 2015-05, Vol.74 (5), p.795-798

2015

Volltextzugriff (PDF)

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis

Rheumatology (Oxford, England), 2015-11, Vol.54 (11), p.2015-2024

2015

Volltextzugriff (PDF)

Systemic sclerosis skin is a primed microenvironment for soft tissue calcification—a hypothesis

Rheumatology (Oxford, England), 2021-06, Vol.60 (6), p.2517-2527

2021

Volltextzugriff (PDF)

Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases

Rheumatology (Oxford, England), 2018-04, Vol.57 (4), p.757-759

2018

Volltextzugriff (PDF)

Ex Situ and Operando Studies on the Role of Copper in Cu-Promoted SiO2–MgO Catalysts for the Lebedev Ethanol-to-Butadiene Process

ACS catalysis, 2015-10, Vol.5 (10), p.6005-6015

2015

Volltextzugriff (PDF)

BSR and BHPR guideline for the treatment of systemic sclerosis

Rheumatology (Oxford, England), 2016-10, Vol.55 (10), p.1906-1910

2016

Volltextzugriff (PDF)

Digital ulcers in systemic sclerosis

Rheumatology (Oxford, England), 2017-01, Vol.56 (1), p.14-25

2017

Volltextzugriff (PDF)

Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?

Rheumatology, 2022-11, Vol.61 (11), p.4384-4396

2022

Volltextzugriff (PDF)

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

Haematologica (Roma), 2024-02, Vol.109 (2), p.689

2024

Volltextzugriff (PDF)

New perspectives in the imaging of Raynaud's phenomenon

European journal of rheumatology, 2020-10, Vol.7 (Suppl 3), p.S212-221

2020

Volltextzugriff (PDF)

Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis

Scientific reports, 2022-02, Vol.12 (1), p.2893-2893, Article 2893

2022

Volltextzugriff (PDF)

Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland

Arthritis care & research (2010), 2010-02, Vol.62 (2), p.213-218

2010

Volltextzugriff (PDF)

Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia

The American journal of gastroenterology, 2018-02, Vol.113 (2), p.216-224

2018

Volltextzugriff (PDF)

A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud's

Rheumatology (Oxford, England), 2023-02, Vol.62 (2), p.824-828

2023

Volltextzugriff (PDF)

Photoacoustic imaging is a novel tool to measure finger artery structure and oxygenation in patients with SSc

Scientific reports, 2022-11, Vol.12 (1), p.20446-20446, Article 20446

2022

Volltextzugriff (PDF)

Contemporary management of Raynaudʼs phenomenon and digital ischaemic complications

Current opinion in rheumatology, 2011-11, Vol.23 (6), p.555-561

Herrick, Ariane L

2011

Volltextzugriff (PDF)

Malnutrition in systemic sclerosis

Rheumatology (Oxford, England), 2012-10, Vol.51 (10), p.1747-1756

2012

Volltextzugriff (PDF)

Evidence-based management of Raynaud’s phenomenon

Therapeutic Advances in Musculoskeletal Disease, 2017-12, Vol.9 (12), p.317-329

Herrick, Ariane L.

2017

Volltextzugriff (PDF)

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

Arthritis research & therapy, 2019-06, Vol.21 (1), p.147-147, Article 147

2019

Volltextzugriff (PDF)

1 – 25 von 1.930

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.587)
Mit Volltextzugriff
(1.569)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.913)
Japanisch
(183)
Französisch
(16)
Deutsch
(2)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(996)
Life Sciences & Biomedicine
(829)
Humans
(620)
Female
(384)
Male
(335)
Middle Aged
(268)
Biological And Medical Sciences
(265)
Rheumatology
(265)
Adult
(264)
Medical Sciences
(215)
Aged
(196)
Systemic Sclerosis
(166)
Physical Sciences
(131)
Animals
(129)
Scleroderma
(104)
Scleroderma, Systemic - Complications
(82)
Risk Factors
(76)
Case-Control Studies
(73)
Adolescent
(70)
Chemistry
(66)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The pathogenesis, diagnosis and treatment of Raynaud phenomenon

Pathogenesis of Raynaud's phenomenon

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need

Recent advances in the pathogenesis and management of Raynaudʼs phenomenon and digital ulcers

Onset of breast development in a longitudinal cohort

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis

Systemic sclerosis skin is a primed microenvironment for soft tissue calcification—a hypothesis

Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases

Ex Situ and Operando Studies on the Role of Copper in Cu-Promoted SiO2–MgO Catalysts for the Lebedev Ethanol-to-Butadiene Process

BSR and BHPR guideline for the treatment of systemic sclerosis

Digital ulcers in systemic sclerosis

Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?

Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant

New perspectives in the imaging of Raynaud's phenomenon

Polarisation-sensitive optical coherence tomography measurement of retardance in fibrosis, a non-invasive biomarker in patients with systemic sclerosis

Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland

Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia

A phase 2 trial investigating the effects of the angiotensin II type 2 receptor agonist C21 in systemic sclerosis-related Raynaud's

Photoacoustic imaging is a novel tool to measure finger artery structure and oxygenation in patients with SSc

Contemporary management of Raynaudʼs phenomenon and digital ischaemic complications

Malnutrition in systemic sclerosis

Evidence-based management of Raynaud’s phenomenon

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

Suchergebnisse filtern